Literature DB >> 29858003

Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study.

Emmely W de Roos1, Lies Lahousse2, Katia M C Verhamme3, Gert-Jan Braunstahl4, M Arfan Ikram5, Johannes C C M In 't Veen4, Bruno H Ch Stricker6, Guy G O Brusselle7.   

Abstract

BACKGROUND: Little is known on the prevalence and characteristics of asthma in middle-aged and older adults, since previous studies mainly focused on children and young adults. Therefore, the aim was to investigate the prevalence of physician-diagnosed asthma and its comorbidities, in a population-based cohort of adults 45 years of age and over.
METHODS: We identified participants with physician-diagnosed asthma in the Rotterdam Study; a prospective population-based cohort in the Netherlands. Pulmonary function measurements and comorbidities of the asthma cases were assessed at baseline and compared to those of the general population.
RESULTS: Out of 14,621 participants (mean age 65.5 years; 59% women), 524 subjects (31.5%males) had physician-diagnosed asthma at study entry, implicating an asthma prevalence of 3.6% [95% Confidence Interval (CI) 3.3%-3.9%] (2.8% in males and 4.2% in females). Asthmatic subjects had a significantly higher prevalence of obesity and depressive symptoms (Odds Ratio [OR]: 2,02 [95% CI 1,66-2,47] and [OR]: 2,01 [95% CI 1,52-2,66] respectively). Longer duration of asthma and current smoking were associated with lower lung function in asthmatic subjects.
CONCLUSION: Four percent of middle-aged and older adults have physician-diagnosed asthma. These adult asthmatics suffer more frequently from obesity and depression than subjects without obstructive lung disease.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asthma; Comorbidity; General population; Older adults

Mesh:

Year:  2018        PMID: 29858003     DOI: 10.1016/j.rmed.2018.04.006

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  10 in total

1.  Blood eosinophil level and lung function trajectories: cross-sectional and longitudinal studies in European cohorts.

Authors:  Ida Mogensen; Judith M Vonk; Sara R A Wijnant; Xingwu Zhou; H Marike Boezen; Guy Brusselle; Lies Lahousse; Christer Janson; Andrei Malinovschi
Journal:  ERJ Open Res       Date:  2020-10-05

2.  Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort study.

Authors:  Silvan Licher; Alis Heshmatollah; Kimberly D van der Willik; Bruno H Ch Stricker; Rikje Ruiter; Emmely W de Roos; Lies Lahousse; Peter J Koudstaal; Albert Hofman; Lana Fani; Guy G O Brusselle; Daniel Bos; Banafsheh Arshi; Maryam Kavousi; Maarten J G Leening; M Kamran Ikram; M Arfan Ikram
Journal:  PLoS Med       Date:  2019-02-04       Impact factor: 11.069

3.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

4.  Sarcopenia in older people with chronic airway diseases: the Rotterdam study.

Authors:  Elizabeth Benz; Katerina Trajanoska; Josje D Schoufour; Lies Lahousse; Emmely W de Roos; Natalie Terzikhan; Carolina Medina-Gomez; Katia Verhamme; Ross Williams; Bruno H Stricker; Oscar H Franco; M Arfan Ikram; Fernando Rivadeneira; Guy Brusselle
Journal:  ERJ Open Res       Date:  2021-03-08

5.  Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study.

Authors:  Elizabeth Benz; Sara R A Wijnant; Katerina Trajanoska; Johnmary T Arinze; Emmely W de Roos; Maria de Ridder; Ross Williams; Frank van Rooij; Katia M C Verhamme; M Arfan Ikram; Bruno H Stricker; Fernando Rivadeneira; Lies Lahousse; Guy G Brusselle
Journal:  ERJ Open Res       Date:  2022-01-10

6.  Sex-specific patterns and lifetime risk of multimorbidity in the general population: a 23-year prospective cohort study.

Authors:  Premysl Velek; Annemarie I Luik; Guy G O Brusselle; Bruno Ch Stricker; Patrick J E Bindels; Maryam Kavousi; Brenda C T Kieboom; Trudy Voortman; Rikje Ruiter; M Arfan Ikram; M Kamran Ikram; Evelien I T de Schepper; Silvan Licher
Journal:  BMC Med       Date:  2022-09-08       Impact factor: 11.150

7.  Incidence and predictors of asthma exacerbations in middle-aged and older adults: the Rotterdam Study.

Authors:  Emmely W de Roos; Lies Lahousse; Katia M C Verhamme; Gert-Jan Braunstahl; Johannes J C C M In 't Veen; Bruno H Stricker; Guy G O Brusselle
Journal:  ERJ Open Res       Date:  2021-07-12

8.  Pathology-confirmed versus non pathology-confirmed cancer diagnoses: incidence, participant characteristics, and survival.

Authors:  Kimberly D van der Willik; Liliana P Rojas-Saunero; Jeremy A Labrecque; M Arfan Ikram; Sanne B Schagen; Bruno H Stricker; Rikje Ruiter
Journal:  Eur J Epidemiol       Date:  2019-12-20       Impact factor: 8.082

9.  Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study.

Authors:  Johnmary T Arinze; Emmely W de Roos; Leila Karimi; Katia M C Verhamme; Bruno H Stricker; Guy G Brusselle
Journal:  ERJ Open Res       Date:  2020-04-19

10.  Smoking Status Modifies the Relationship between Th2 Biomarkers and Small Airway Obstruction in Asthma.

Authors:  Shuyuan Chu; Libing Ma; Jianghong Wei; Jiying Wang; Qing Xu; Meixi Chen; Ming Jiang; Miao Luo; Jingjie Wu; Lin Mai; Guofang Tang; Biwen Mo
Journal:  Can Respir J       Date:  2021-11-28       Impact factor: 2.409

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.